Rosco Diagnostica ApS: Financial statements 2022
CVR: 27210341
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
Rosco Diagnostica ApS (CVR 27210341) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,637,113 and a net result of DKK 91,942 compared with DKK 145,625 the year before. That is an increase of 7% compared with the year before. Equity in the 2022 report amounted to DKK 7,646,236. The solvency ratio was 73.3%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 3,637,113
- Profit/Loss
- DKK 91,942
- Equity
- DKK 7,646,236
- Total Assets
- DKK 10,428,473
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3.6M | 92K | 7.6M | 5 |
| 2021 | - | 3.4M | 146K | 7.6M | 5 |
| 2020 | - | 3.4M | -349K | 7.4M | 6 |
| 2019 | - | 4.2M | 266K | 7.8M | 9 |
| 2018 | - | 5.7M | 1.3M | 7.5M | 9 |
Official annual report
Keep an eye on Rosco Diagnostica ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Rosco Diagnostica ApS
Rosco Diagnostica ApS is a Danish company of the type Anpartsselskab based in Albertslund, founded in 2003. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named ROSCO DIAGNOSTICA A/S and ROSCA DIAGNOSTICA A/S. The management consists of Søren Anker Nielsen. The company is owned by Alpine-Bio ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 1,512,589 and a net result of DKK -649,434 compared with DKK -820,396 the year before. Equity in the 2025 report amounted to DKK 488,626.